4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
A guide to tesamorelin (Egrifta) dosing, pharmacogenomics, and safety monitoring for patients of Black or African ancestry, including ethnicity-stratified trial data and practical prescribing guidance.
A clinical deep-dive into tesamorelin efficacy, pharmacogenomics, and dosing considerations specific to Black and African ancestry patients, with inline citations to primary sources.
A clinical deep-dive into how tesamorelin (Egrifta) performs in East Asian patients, covering ethnicity-stratified subgroup data, pharmacogenomics, lower BMI thresholds, and practical dosing considerations.
Evidence-based guide to tesamorelin dosing considerations for South Asian patients, including pharmacogenomic factors, metabolic risk differences, and clinical monitoring recommendations.